Search Results - "Richman, D P"

Refine Results
  1. 1

    An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis by SANDERS, D. B, HART, I. K, MANTEGAZZA, R, SHUKLA, S. S, SIDDIQI, Z. A, DE BAETS, M. H. V, MELMS, A, NICOLLE, M. W, SOLOMONS, N, RICHMAN, D. P

    Published in Neurology (05-08-2008)
    “…This prospective, randomized, double-blind, placebo-controlled, phase III trial assessed the efficacy, safety, and tolerability of mycophenolate mofetil (MMF)…”
    Get full text
    Journal Article
  2. 2

    Lipoprotein-like receptor 4 antibodies in myasthenia gravis: pathogenic or protective by Richman, D. P.

    Published in European journal of neurology (01-11-2016)
    “…Click here to view the accompanying paper in this issue…”
    Get full text
    Journal Article
  3. 3

    Presynaptic congenital myasthenic syndrome due to quantal release deficiency by MASELLI, R. A, KONG, D. Z, BOWE, C. M, MCDONALD, C. M, ELLIS, W. G, AGIUS, M. A, GOMEZ, C. M, RICHMAN, D. P, WOLLMANN, R. L

    Published in Neurology (24-07-2001)
    “…To provide clinical, electrophysiologic, and ultrastructural findings in three patients with a presynaptic congenital myasthenic syndrome (CMS). Familial…”
    Get full text
    Journal Article
  4. 4

    Transcervical thymectomy for myasthenia gravis by DeFilippi, Vincent J., Richman, David P., Ferguson, Mark K.

    Published in The Annals of thoracic surgery (1994)
    “…The use of transcervical thymectomy in the treatment of myasthenia gravis remains controversial. We retrospectively reviewed our experience with this procedure…”
    Get full text
    Journal Article
  5. 5

    Neuromuscular transmission in amyotrophic lateral sclerosis by Maselli, R A, Wollman, R L, Leung, C, Distad, B, Palombi, S, Richman, D P, Salazar-Grueso, E F, Roos, R P

    Published in Muscle & nerve (01-11-1993)
    “…The functional and structural characteristics of the neuromuscular junction were studied in anconeus muscle biopsies of 10 patients with amyotrophic lateral…”
    Get more information
    Journal Article
  6. 6

    Cluster of wound botulism in California: Clinical, electrophysiologic, and pathologic study by Maselli, Ricardo A., Ellis, William, Mandler, Raul N., Sheikh, Firdos, Venton, Grace, Knox, Stephen, Salari-Namin, Hamid, Agius, Mark, Wollmann, Robert L., Richman, David P.

    Published in Muscle & nerve (01-10-1997)
    “…Over a period of 15 months we have seen 6 patients with long‐standing history of subcutaneous heroin injections who experienced acute blurred vision,…”
    Get full text
    Journal Article
  7. 7

    Inflammation at the neuromuscular junction in myasthenia gravis by MASELLI, R. A, RICHMAN, D. P, WOLLMANN, R. L

    Published in Neurology (01-09-1991)
    “…To better define the pathogenic mechanisms in the antibody-mediated autoimmune disease myasthenia gravis (MG), we analyzed the morphology and electrophysiology…”
    Get full text
    Journal Article
  8. 8

    Monoclonal antibodies as probes of the alpha-bungarotoxin and cholinergic binding regions of the acetylcholine receptor by Mihovilovic, M., Richman, D.P.

    Published in The Journal of biological chemistry (15-04-1987)
    “…We have probed the acetylcholine receptor (AcChR) molecule with six anti-AcChR monoclonal antibodies (mAbs) whose binding to the AcChR is inhibited or blocked…”
    Get full text
    Journal Article
  9. 9

    Anti-Acetylcholine Receptor Antibodies Directed against the α -bungarotoxin Binding Site Induce a Unique Form of Experimental Myasthenia by Gomez, Christopher M., Richman, David P.

    “…Of seven rat monoclonal antibodies directed against nicotinic acetylcholine receptor, the three whose binding was blocked by α -bungarotoxin produced acute…”
    Get full text
    Journal Article
  10. 10

    Myasthenia gravis: pathogenesis and treatment by Richman, D P, Agius, M A

    Published in Seminars in neurology (01-06-1994)
    “…Much is known about the pathogenesis of MG. This information has provided a rational basis for treatment of the disease, which is very effective. On the other…”
    Get more information
    Journal Article
  11. 11

    Monoclonal anti-acetylcholine receptor antibodies with differing capacities to induce experimental autoimmune myasthenia gravis by Gomez, CM, Richman, DP

    Published in The Journal of immunology (1950) (01-07-1985)
    “…To study the characteristics of the individual autoantibodies that are important in the development of an autoimmune disease, we produced 26 anti-acetylcholine…”
    Get full text
    Journal Article
  12. 12

    Effects of a monoclonal anti-acetylcholine receptor antibody on the avian end-plate by Maselli, R A, Nelson, D J, Richman, D P

    Published in The Journal of physiology (01-04-1989)
    “…1. The effects of anti-acetylcholine receptor (AChR) monoclonal antibodies (mAbs) 370 and 132A on miniature end-plate potentials (MEPPs) and end-plate currents…”
    Get full text
    Journal Article
  13. 13

    Nicotinic Acetylcholine Receptor: Evidence for a Functionally Distinct Receptor on Human Lymphocytes by Richman, David P., Barry G. W. Arnason

    “…The presence of three distinct cholinergic receptors on human lymphocytes was suggested by the effects of carbamoylcholine on lymphocyte proliferation in…”
    Get full text
    Journal Article
  14. 14

    Modification of alpha-bungarotoxin and cholinergic ligand-binding properties of Torpedo acetylcholine receptor by a monoclonal anti-acetylcholine receptor antibody by Mihovilovic, M, Richman, D P

    Published in The Journal of biological chemistry (25-12-1984)
    “…The interaction between acetylcholine receptor (AcChR) and monoclonal antibody (mab) 247G–whose binding is blocked by the presence of alpha-bungarotoxin (alpha…”
    Get full text
    Journal Article
  15. 15

    Thymectomy in the treatment of ocular myasthenia gravis by Roberts, Peter F., Venuta, Federico, Rendina, Erino, De Giacomo, Tiziana, Coloni, Giorgio F., Follette, David M., Richman, David P., Benfield, John R.

    “…Background: Thymectomy is an effective and accepted treatment for myasthenia gravis, but thymectomy for ocular myasthenia gravis (Osserman stage I) is…”
    Get full text
    Journal Article
  16. 16

    Acquired myasthenia gravis. Immunopathology by Richman, D P, Agius, M A

    Published in Neurologic clinics (01-05-1994)
    “…Much of the remarkable advance in our understanding of the immunopathology of MG relates to the availability of two gifts of nature that permit the ready…”
    Get more information
    Journal Article
  17. 17
  18. 18

    Refractoriness to a second episode of experimental myasthenia gravis. Correlation with AChR concentration and morphologic appearance of the postsynaptic membrane by Corey, AL, Richman, DP, Agius, MA, Wollmann, RL

    Published in The Journal of immunology (1950) (15-05-1987)
    “…Rats injected with anti-acetylcholine receptor (anti-AChR)2 monoclonal antibodies (mAb) develop the acute phase of experimental autoimmune myasthenia gravis…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Induction of the morphologic changes of both acute and chronic experimental myasthenia by monoclonal antibody directed against acetylcholine receptor by GOMEZ, C. M, WOLLMANN, R. L, RICHMAN, D. P

    Published in Acta neuropathologica (01-01-1984)
    “…To investigate pathogenic mechanisms in experimental autoimmune myasthenia gravis (EAMG) and myasthenia gravis (MG), we studied the acute and chronic effects…”
    Get full text
    Journal Article